Results can be thrust from bench to bedside, but there is also much to be learned by pushing the other way. Heidi Ledford tells tales of clinical trials that have prompted a change in tack.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
Molecular Cancer Open Access 19 February 2018
-
The institutional review board is an impediment to human research: the result is more animal-based research
Philosophy, Ethics, and Humanities in Medicine Open Access 07 June 2011
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mishra, R. A drug that works — for some. The Boston Globe (24 November 2003).
Metro, G. et al. Rev. Recent Clin. Trials 1, 1–13 (2006).
Lynch, T. J. et al. N. Engl. J. Med. 350, 2129–2139 (2004).
Paez, J. G. et al. Science 304, 1497–1500 (2004).
Pao, W. et al. Proc. Natl Acad. Sci. USA 101, 13306–13311 (2004).
Engelman, J. A. et al. Science 316, 1039–1043 (2007).
Li, Z. et al. Science 296, 497 (2002).
Deichmann, A. et al. J. Clin. Invest. 117, 2225–2232 (2007).
Schwarzwaelder, K. et al. J. Clin. Invest. 117, 2241–2249 (2007).
Hacein-Bey-Abina, S. et al. Science 302, 415–419 (2003).
Thornhill, S. I. et al. Mol. Ther. 16, 590–598 (2008).
Additional information
See Editorial, page 823, and online at http://tinyurl.com/3tt3y3 .
Related links
Related links
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. Translational Research: The full cycle. Nature 453, 843–845 (2008). https://doi.org/10.1038/453843a
Published:
Issue Date:
DOI: https://doi.org/10.1038/453843a
This article is cited by
-
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
Molecular Cancer (2018)
-
Anecdotes from ITMAT: Building Capacity for Translational Science
Clinical Pharmacology & Therapeutics (2013)
-
The institutional review board is an impediment to human research: the result is more animal-based research
Philosophy, Ethics, and Humanities in Medicine (2011)
-
Reverse translation: clearing a path from bedside to bench
Nature (2008)
